VOLITIONRX LIMITED

Analyst Reco. VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
0.7276 ^USD	-2.01%		-9.05%	+1.48%

May. 14	Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024
May. 13	VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.50 From $2.10, Maintains Overweight Rating	Nov. 16	MT
Cantor Fitzgerald Adjusts Price Target on VolitionRX to $2.10 From $3, Keeps Overweight Rating	23-08-16	MT
Inflation, Rate-Hike Concerns Push US Equity Futures Lower	23-02-17	MT
Benchmark Capital Downgrades VolitionRX to Hold From Buy	23-02-01	MT
EF Hutton Initiates VolitionRX at Buy With $6 Price Target	22-12-19	MT
Maxim Group Adjusts Price Target on VolitionRX to $5 From $8, Reiterates Buy Rating	22-08-23	MT
Aegis Capital Adjusts Price Target on VolitionRX to $6 From $9, Reiterates Buy Rating	22-08-15	MT
VOLITIONRX : Cantor Fitzgerald Initiates VolitionRX at Overweight With $8 Price Target	21-03-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer